Nengte Technology (002102.SZ): Currently, the market price of vitamin E has rebounded, but the industry price has a lag period of about two months for the company's impact.

During the Investor Visit to Listed Companies event, Nengte Technology (002102.SZ) stated that Yiman Health Industry (Jingzhou) Co., Ltd., a joint venture between Nengte and DSM, completed the intelligent upgrade of its vitamin E production line and achieved full production and standardization. The production line will steadily operate and generate profits in 2022, and has maintained a good level of profitability despite facing intense competition in the market from 2023 to the present. In the first half of 2024, Nengte Technology and its joint venture Yiman Health Industry were impacted by fierce market competition, resulting in a decline in product profitability compared to the same period last year. The company is in a fierce competition.

Gelonghui FinanceJul 18 05:26 ET

HuBei NengTer Technology: Announcement of 2024 interim performance forecast.

Sensex a shareJul 12 12:00 ET · Announcements

Nengte Technology (002102.SZ): Net income in the first half of the year is expected to decrease by 76.78%-83.42%.

On July 12th, Gleamray Technology (002102.SZ) announced its performance forecast for the first half of 2024. The net income attributable to shareholders of the listed company is expected to be between 50 million yuan and 70 million yuan, a decrease of 76.78% to 83.42% compared with the same period last year; the net income after deducting non-recurring gains and losses is expected to be between 45 million yuan and 60 million yuan, a decrease of 55.38% to 66.53% compared with the same period last year; and the basic earnings per share are expected to be between 0.019 yuan/share and 0.0266 yuan/share. The violation of regulations by the original controlling shareholder, the Lin family, led to this result.

Gelonghui FinanceJul 12 04:20 ET

Risks To Shareholder Returns Are Elevated At These Prices For HuBei NengTer Technology CO.,Ltd (SZSE:002102)

With a median price-to-earnings (or "P/E") ratio of close to 29x in China, you could be forgiven for feeling indifferent about HuBei NengTer Technology CO.,Ltd's (SZSE:002102) P/E ratio of 26.8x. Wh

Simply Wall StJul 2 18:35 ET

Nengte Technology (002102.SZ): plans to publicly transfer 100% equity of Shanghai Wutian, with a listing reserve price of 800 million yuan.

On June 24th, Gelunhui announced that Nengte Technology (002102.SZ) held the 16th meeting of the seventh board of directors on April 1, 2024, and the first temporary shareholders' meeting of 2024 on April 17, 2024. The board passed a proposal to publicly list and transfer the 100% equity of its wholly-owned subsidiary Shanghai Wutian Industrial Co., Ltd. (hereinafter referred to as 'Wutian') at the Jingzhou Property Rights Exchange of the Wuhan Optics Valley Joint Property Rights Trading Company.

Gelonghui FinanceJun 24 06:20 ET

Has HuBei NengTer Technology CO.,Ltd's (SZSE:002102) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Most readers would already be aware that HuBei NengTer TechnologyLtd's (SZSE:002102) stock increased significantly by 13% over the past three months. We wonder if and what role the company's financi

Simply Wall StJun 3 18:09 ET